Clinical trial
Relative Bioavailability of an Extemporaneous Oral Suspension of Aprepitant in Adolescents
NCT01249001 is registered in ClinicalTrials.gov with The Hospital for Sick Children as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Relative Bioavailability of an Extemporaneous Oral Suspension of Aprepitant in Adolescents
- Lead sponsor
- The Hospital for Sick Children
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- October 31, 2010
- Completion date
- September 28, 2016
- Enrollment
- 4 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.